Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CLEC4M encodes a transmembrane receptor and is often referred to as L-SIGN because of its expression in the endothelial cells of the lymph nodes and liver. Additionally we are shipping C-Type Lectin Domain Family 4, Member M Proteins (10) and C-Type Lectin Domain Family 4, Member M Kits (1) and many more products for this protein.
Showing 10 out of 55 products:
Human Monoclonal CLEC4M Primary Antibody for BR, CyTOF - ABIN5012885
Ludwig, Lekkerkerker, Depla, Bosman, Musters, Depraetere, van Kooyk, Geijtenbeek: Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. in Journal of virology 2004
Show all 7 Pubmed References
Human Monoclonal CLEC4M Primary Antibody for FACS - ABIN4898522
Mukherjee, Dowd, Manhart, Ledgerwood, Durbin, Whitehead, Pierson: Mechanism and significance of cell type-dependent neutralization of flaviviruses. in Journal of virology 2014
Show all 3 Pubmed References
DC-SIGNR promoted gastric cancer liver metastasis mediated with HNRNPKP2 which expression was regulated by STAT5A (show STAT5A Antibodies). And HNRNPKP2 decreased the expression of downstream target gene CXCR4 (show CXCR4 Antibodies). These findings indicated potential therapeutic candidates for gastric cancer liver metastasis.
the neck domains of DC-SIGN (show CD209 Antibodies) and DC-SIGNR can contribute to the different functions of these receptors by presenting the sugar-binding sites in different contexts.
Together, these studies confirm a role for C-type lectin (show MBL2 Antibodies) receptors DC-SIGN (show CD209 Antibodies) and L-SIGN as attachment factors and entry receptors for human metapneumovirus infection.
DC-SIGNR VNTR and DC-SIGN (show CD209 Antibodies) VNTR were not associated with the risk of pulmonary tuberculosis in a sample of Iranian population
CD209L variation may influence susceptibility to HIV-1, response to treatment, and disease progression.
DC-SIGNR expression in peripheral blood mononuclear cells was higher in HIV-1-infected patients, and its positive correlation with viral load and negative with CD4 (show CD4 Antibodies)+ T cells counts suggest a potential role of DC-SIGNR in HIV-1 infection.
Study demonstrated that serum levels of DC-SIGNR in lung cancer patients were significantly lower than those in healthy individuals, and correlated significantly with brain metastasis and serum NK cells percentage.
Genetic variations in STXBP5 (show STXBP5 Antibodies) and CLEC4M are associated with VWF (show VWF Antibodies) level variation in type 1, but not in type 2 von Willebrand disease.
of an association between CD209 (show CD209 Antibodies) and CD209L polymorphisms and tuberculosis development in a Brazilian population
DC-SIGN (show CD209 Antibodies) and DC-SIGNR are blood-based molecular markers that can potentially be used for the diagnosis of early stage patients
This gene encodes a transmembrane receptor and is often referred to as L-SIGN because of its expression in the endothelial cells of the lymph nodes and liver. The encoded protein is involved in the innate immune system and recognizes numerous evolutionarily divergent pathogens ranging from parasites to viruses, with a large impact on public health. The protein is organized into three distinct domains: an N-terminal transmembrane domain, a tandem-repeat neck domain and C-type lectin carbohydrate recognition domain. The extracellular region consisting of the C-type lectin and neck domains has a dual function as a pathogen recognition receptor and a cell adhesion receptor by binding carbohydrate ligands on the surface of microbes and endogenous cells. The neck region is important for homo-oligomerization which allows the receptor to bind multivalent ligands with high avidity. Variations in the number of 23 amino acid repeats in the neck domain of this protein are common and have a significant impact on ligand binding ability. This gene is closely related in terms of both sequence and function to a neighboring gene (GeneID 30835\; often referred to as DC-SIGN or CD209). DC-SIGN and L-SIGN differ in their ligand-binding properties and distribution. Alternative splicing results in multiple variants.
C-type lectin domain family 4 member M
, CD209 antigen-like protein 1
, CD299 antigen
, DC-SIGN-related protein
, dendritic cell-specific ICAM-3-grabbing non-integrin 2
, liver/lymph node-specific ICAM-3 grabbing non-integrin
, liver/lymph node-specific ICAM-3-grabbing non-integrin
, mannose binding C-type lectin DC-SIGNR
, CD209b antigen